UniProt ID | ACKR3_HUMAN | |
---|---|---|
UniProt AC | P25106 | |
Protein Name | Atypical chemokine receptor 3 | |
Gene Name | ACKR3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 362 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein. Cytoplasm, perinuclear region. Early endosome. Recycling endosome. Predominantly localizes to endocytic vesicles, and upon stimulation by the ligand is internalized via clathrin-coated pits in a beta-arrest |
|
Protein Description | Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Acts as a receptor for chemokines CXCL11 and CXCL12/SDF1. Chemokine binding does not activate G-protein-mediated signal transduction but instead induces beta-arrestin recruitment, leading to ligand internalization and activation of MAPK signaling pathway. Required for regulation of CXCR4 protein levels in migrating interneurons, thereby adapting their chemokine responsiveness. In glioma cells, transduces signals via MEK/ERK pathway, mediating resistance to apoptosis. Promotes cell growth and survival. Not involved in cell migration, adhesion or proliferation of normal hematopoietic progenitors but activated by CXCL11 in malignant hemapoietic cells, leading to phosphorylation of ERK1/2 (MAPK3/MAPK1) and enhanced cell adhesion and migration. Plays a regulatory role in CXCR4-mediated activation of cell surface integrins by CXCL12. Required for heart valve development. Acts as coreceptor with CXCR4 for a restricted number of HIV isolates.. | |
Protein Sequence | MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | N-linked_Glycosylation | FDYSEPGNFSDISWP CCCCCCCCCCCCCCC | UniProtKB CARBOHYD | ||
22 | N-linked_Glycosylation | SDISWPCNSSDCIVV CCCCCCCCCCCEEEE | UniProtKB CARBOHYD | ||
39 | N-linked_Glycosylation | VMCPNMPNKSVLLYT EECCCCCCCHHHHHH | UniProtKB CARBOHYD | ||
143 | Phosphorylation | TCMSVDRYLSITYFT HHHCCCCCHHEEEEC | 23663014 | ||
145 | Phosphorylation | MSVDRYLSITYFTNT HCCCCCHHEEEECCC | 23663014 | ||
147 | Phosphorylation | VDRYLSITYFTNTPS CCCCHHEEEECCCHH | 23663014 | ||
148 | Phosphorylation | DRYLSITYFTNTPSS CCCHHEEEECCCHHH | 23663014 | ||
150 | Phosphorylation | YLSITYFTNTPSSRK CHHEEEECCCHHHHH | 23663014 | ||
152 | Phosphorylation | SITYFTNTPSSRKKM HEEEECCCHHHHHHH | 23663014 | ||
154 | Phosphorylation | TYFTNTPSSRKKMVR EEECCCHHHHHHHHH | 23663014 | ||
155 | Phosphorylation | YFTNTPSSRKKMVRR EECCCHHHHHHHHHH | 23663014 | ||
328 | Ubiquitination | NYRYELMKAFIFKYS HHHHHHHHHHHHHHH | 23000965 | ||
333 | Ubiquitination | LMKAFIFKYSAKTGL HHHHHHHHHHHCCCC | 23000965 | ||
334 | Phosphorylation | MKAFIFKYSAKTGLT HHHHHHHHHHCCCCC | 19835603 | ||
335 | Phosphorylation | KAFIFKYSAKTGLTK HHHHHHHHHCCCCCH | 19835603 | ||
337 | Ubiquitination | FIFKYSAKTGLTKLI HHHHHHHCCCCCHHH | 25015289 | ||
338 | Phosphorylation | IFKYSAKTGLTKLID HHHHHHCCCCCHHHC | 19835603 | ||
342 | Ubiquitination | SAKTGLTKLIDASRV HHCCCCCHHHCHHHC | 23503661 | ||
347 | Phosphorylation | LTKLIDASRVSETEY CCHHHCHHHCCHHHH | 30266825 | ||
350 | Phosphorylation | LIDASRVSETEYSAL HHCHHHCCHHHHHHH | 19664994 | ||
352 | Phosphorylation | DASRVSETEYSALEQ CHHHCCHHHHHHHHH | 30266825 | ||
354 | Phosphorylation | SRVSETEYSALEQST HHCCHHHHHHHHHHC | 21955146 | ||
355 | Phosphorylation | RVSETEYSALEQSTK HCCHHHHHHHHHHCC | 30266825 | ||
360 | Phosphorylation | EYSALEQSTK----- HHHHHHHHCC----- | 23403867 | ||
361 | Phosphorylation | YSALEQSTK------ HHHHHHHCC------ | 21955146 | ||
362 | Ubiquitination | SALEQSTK------- HHHHHHCC------- | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ACKR3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACKR3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACKR3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ATPB_HUMAN | ATP5B | physical | 26186194 | |
ATPA_HUMAN | ATP5A1 | physical | 26186194 | |
ATPD_HUMAN | ATP5D | physical | 26186194 | |
ATPO_HUMAN | ATP5O | physical | 26186194 | |
ATPA_HUMAN | ATP5A1 | physical | 26496610 | |
ATPB_HUMAN | ATP5B | physical | 26496610 | |
ATPO_HUMAN | ATP5O | physical | 26496610 | |
ESPL1_HUMAN | ESPL1 | physical | 26496610 | |
ATP5H_HUMAN | ATP5H | physical | 26496610 | |
RM04_HUMAN | MRPL4 | physical | 26496610 | |
UBR7_HUMAN | UBR7 | physical | 26496610 | |
HECD2_HUMAN | HECTD2 | physical | 26496610 | |
ATPB_HUMAN | ATP5B | physical | 28514442 | |
ATPA_HUMAN | ATP5A1 | physical | 28514442 | |
ATPO_HUMAN | ATP5O | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...